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NC-ND license (http://creativecommoAbstract Background/Introduction: Ischemic preconditioning is a method in which brief pe-
riods of ischemia render tissues resistant to injury resulting from prolonged ischemia and re-
perfusion, so-called ischemiaereperfusion injury.
Purpose: To elucidate the possible protective role of ischemic preconditioning in rat livers with
ischemiaereperfusion injury.
Methods: Rats were first allocated to either a sham control or an ischemic preconditioning group.
On the following day, the rats from each groupwere administered either 30minutes or 45minutes
hepatic ischemia. Next, rat liverswere harvested formeasuring proliferating cell nuclear antigen,
heme oxygenase-1, inducible nitric oxide synthase, and heat shock protein 70 mRNA levels.
Results: Bothproliferatingcell nuclear antigenandhemeoxygenase-1expression increased signif-
icantly after 45minutes hepatic ischemia comparedwith thoseafter 30minutes hepatic ischemia,
but they decreased significantly with ischemic preconditioning. However, ischemic precondition-
ing did not affect inducible nitric oxide synthase or heat shock protein 70 expression.
Conclusion: From the preliminary findings, further elucidation is warranted.
Copyright ª 2016, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
During ischemic preconditioning, brief periods of tissue
ischemia are used to render tissue resistant to injuryport no conflict of interest.
of Surgery, Kaohsiung Chang
i Road, Niao-Sung District,
om (S.-M. Sheen-Chen).
03.003
urgical Association. Published by
ns.org/licenses/by-nc-nd/4.0/).resulting from prolonged ischemia and reperfusion, so-
called ischemiaereperfusion injury. Hepatic ische-
miaereperfusion injury plays a major role in hepatic
resection and shock, particularly during liver
transplantation.1e4
Hepatic vascular control is commonly used to prevent
massive hemorrhage during hepatectomy. Hepatic vascular
occlusion provides a relatively bloodless operative field,
enabling unhurried, meticulous, and accurate intrahepatic
dissection and hemostasis.5e7Elsevier Taiwan LLC. This is an open access article under the CC BY-
170 S.-C. Kuo et al.Hemeoxygenases (HOs) catalyze the formation of carbon
monoxide (CO), biliverdin, and Fe2þ ions during heme
degradation. HO-1 is the inducible isoform of HO and is
induced for cytoprotection under various stress-related
conditions including hyperemia, hypoxia, and
ischemiaereperfusion.8,9
Nitric oxide (NO) plays a crucial role in maintaining the
hepatic vascular tone.10 NO synthase (NOS) metabolically
produces NO from L-arginine, oxygen, and nicotinamide
adenine dinucleotide phosphate. In the liver, inducible NOS
(iNOS) is a key molecule catalyzing NO synthesis.11,12
Proliferating cell nuclear antigen (PCNA), also called
cyclin, is an auxiliary protein of DNA polymerase-d13; its
expression levels are directly correlated with cell prolifer-
ation and DNA synthesis rates.14 PCNA is synthesized in the
late G1 and S phases and remains present in the nuclei
throughout the cell cycle; thus, the PCNA levels are
correlated with the cell proliferative state.15
2. Methods
This study elucidated the pathophysiology of ische-
miaereperfusion injury in a rat liver model and evaluated
the possible protective role of ischemic preconditioning in
rat livers with ischemiaereperfusion injury.
2.1. Samples and experimental design
We used male SpragueeDawley rats, weighing 250e300 g,
housed in stainless-steel cages under controlled tempera-
ture, humidity, and 12-hour lightedark cycles. They were
allowed free access to food and water before and after
surgery. All the rats received humane care, and the study
protocol complied with the guidelines and animal research
laws of our institution. The study protocol was reviewed
and approved by the Chang Gung Memorial Hospital Animal
Care and Use Committee, Kaohsiung, Taiwan. An intra-
muscular dose of anesthesia containing 30 mg/kg of Zoletil
50 (VIRBAC, France) and 10 mg/kg of Xylazine (Bayer Vital
GmbH, Germany) was administered before surgery. After
surgery, 2200 IU/100 g of penicillin (Y. F. Chemical Ltd.,
Taiwan) and 3 mg/kg of ketorolac tromethamine (Standard
Chem & Pharm Co. Ltd., Taiwan) were administered intra-
muscularly for infection prophylaxis and pain relief,
respectively. The rats were euthanized after the experi-
ments by surgical removal of the heart under anesthesia.
All the rats were divided into six groups (nZ 6 in each
group): Group 1 underwent sham operation (laparotomy
and closure only); Group 2 underwent laparotomy and total
hepatic ischemia, performed using a small atraumatic
clamp to occlude the hepatoduodenal ligament for 10 mi-
nutes (preconditioning); Group 3 underwent laparotomy
and closure, and after 24 hours (Day 2) again underwent
laparotomy followed by total hepatic ischemia for 30 mi-
nutes; Group 4 underwent the 10-minute preconditioning
performed in the Group 2 rats, and after 24 hours (Day 2)
again underwent laparotomy followed by total hepatic
ischemia for 30 minutes; Group 5 underwent laparotomy
and closure, and after 24 hours (Day 2) again underwent
laparotomy followed by total hepatic ischemia for 45 mi-
nutes; and Group 6 underwent the 10-minutepreconditioning performed in the Group 2 rats, and after 24
hours (Day 2) again underwent laparotomy followed by
total hepatic ischemia for 45 minutes.
Tissue samples were harvested as follows: Groups 1 and
2, 24 hours later (Day 2); and Groups 3e6, 15 minutes
(reperfusion) after removal of the temporary occlusion on
Day 2. All harvested hepatic and intestinal tissue samples
were stored in liquid nitrogen until analysis.
2.2. RNA extraction and reverse-transcription
polymerase chain reaction for measuring PCNA,
HO-1, iNOS, and heat shock protein 70 mRNA levels
Total tissue RNA was extracted using guanidine isothiocya-
nate, according to the method described by Chomczynski
and Sacchi.16 First-strand cDNA was synthesized using oligo-
dT primers and avian myeloblastosis virus reverse tran-
scriptase (Promega, Madison, WI, USA).
Hot start Taq polymerase was used for cDNA polymerase
chain reaction (PCR) performed at 88C in a Thermal Cycler
(PerkineElmer, Norwalk, CT, USA). PCNA-specific primers
were added to each tube at a final concentration of
0.2 mmol/L. The 50e30 sequences of the primer pairs and
predicted sizes of the amplified PCR fragments have been
provided previously.17,18 After a 5-minute initial melting
step at 97C, 35e40 PCR cycles were performed as follows:
denaturation at 94C for 1 minute, followed by annealing at
50Ce60C (52C for lipopolysaccharide binding protein
(LBP), 50C for tumor necrosis factor-a, and 60C for CD14)
for 1 minute and then extension at 72C for 2 minutes. The
final cycle was followed by a 10-minute soak at 72C.
We used the constitutively expressed b-actin and glyc-
eraldehyde-3-phosphate dehydrogenase (G3PDH) as inter-
nal controls to confirm the validity of the target gene
expression observed under different experimental condi-
tions for standardizing the PCR products. The cycle
numbers of each primer pair were selected in a linear range
to prevent the plateau effect. The ratios of PCNA/G3PDH,
HO-1/b-actin, INSO/b-actin, and heat shock protein (HSP)
70/b-actin signals were calculated for each sample. Each
experiment included a negative control (a sample RNA, not
subjected to reverse transcription).
2.3. Statistical analysis
All data were statistically analyzed and the results are
presented as means  standard deviations. The data were
compared using the ManneWhitney U test. Differences with
p < 0.05 were considered statistically significant.
3. Results
PCNA expression did not differ significantly between Group
3 (30-minute hepatic ischemia only) and Group 4 (30-
minute hepatic ischemia with preconditioning;
pZ 0.9813). It significantly increased in Group 5 (45-
minute hepatic ischemia only) compared with that in
Group 3 (pZ 0.0007), whereas it decreased significantly in
Group 6 (45-minute ischemia with preconditioning)
compared with that in Group 5 (pZ 0.0065; Figure 1).
Figure 1 Proliferating cell nuclear antigen (PCNA) expression
significantly increased after 45-minute hepatic ischemia alone
(45) compared with that after 30-minute hepatic ischemia
alone (30). PCNA expression after 45-minute ischemia with
preconditioning (45P) was significantly lower than that after
45-minute ischemia alone (45). * pZ 0.9813, ** pZ 0.0065,
*** pZ 0.0007.
Figure 3 The difference in inducible nitric oxide synthase
expression between 30- and 45-minute ischemia alone (30 and
45, respectively) was nonsignificant. Preconditioning induced
no significant difference in either the 30-minute ischemia
groups (30 vs 30P) or the 45-minute ischemia groups (45 vs
45P). * pZ 0.2997, ** pZ 0.0673, *** pZ 0.2131.
Preconditioning in reperfusion injury 171Similarly, HO-1 expression did not differ significantly
between Group 3 and Group 4 (pZ 0.1797). It significantly
increased in Group 5 compared with that in Group 3
(pZ 0.0024), whereas it decreased significantly in Group 6
compared with that in Group 5 (pZ 0.049; Figure 2).
The difference in iNOS expression of Groups 3 and 5 was
nonsignificant (pZ 0.2131). Preconditioning did not cause
any significant difference in iNOS expression in either the
30- or 45-minute ischemia groups (Group 3 vs. Group 4,
pZ 0.2997; Group 5 vs. Group 6, pZ 0.0673; Figure 3).
Similarly, HSP70 expression did not differ significantly
between Groups 3 and 4 (pZ 0.6376), and preconditioningFigure 2 Hemeoxygenase (HO)-1 expression significantly
increased after 45-minute hepatic ischemia alone (45)
compared with that after 30-minute hepatic ischemia alone
(30). HO-1 expression after 45-minute ischemia with pre-
conditioning (45P) was significantly lower than that after 45-
minute ischemia alone (45). * pZ 0.1797, ** pZ 0.049,
*** pZ 0.0024.was also ineffective in both the 30- and 45-minute ischemia
groups (Group 3 vs. Group 4, pZ 0.5041; Group 5 vs. Group
6, pZ 0.9124; Figure 4).
4. Discussion
Ischemic preconditioning before a brief period of vascular
occlusion can render an organ resistant to the damaging
effects of ischemiaereperfusion.1e4,18 This protective ef-
fect was originally described for the heart19 and subse-
quently for the brain, intestine, skeletal muscle, and
liver.18e22
Pang et al23 reported that only a brief period of hepatic
ischemia is required for preconditioning. Xue et al18 hy-
pothesized that the short reperfusion phase of ischemicFigure 4 The difference in heat shock protein 70 expression
after 30- and 45-minute ischemia alone (30 and 45, respec-
tively) was nonsignificant. Preconditioning induced no signifi-
cant difference in either the 30-minute ischemia groups (30 vs
30P) or the 45-minute ischemia groups (45 vs 45P).
* pZ 0.5041, ** pZ 0.9124, *** pZ 0.6376.
172 S.-C. Kuo et al.preconditioning generates reduced reactive oxygen species
(ROS) sufficient for activating redox-sensitive intracellular
signaling pathways. Furthermore, the downstream conse-
quences of such ROS-induced signaling pathways are cyto-
protective to liver cells through the abrogation of cell
death pathways, simulation of antioxidant and other cyto-
protective mechanisms, and initiation of the cell cycle.
However, the actual protective mechanisms of ischemic
preconditioning remain unclear.
HO is the rate-limiting enzyme in heme degradation,
resulting in the formation of CO, biliverdin, and Fe2þ ions.24
Thus far, three distinct HO isoformsdHO-1, HO-2, and HO-
3dhave been identified. HO-1 is constitutively expressed in
the normal gastric, intestinal, and colonic mucosa.25,26 It is
also expressed by all liver and circulating nucleated cells
and can be induced under several stress-related conditions
such as ischemiaereperfusion. HO-1 induction is considered
cytoprotective.8,9 HO-1 inducers may reduce the instances
of hepatic ischemia-reperfusion injury, whereas HO-1 in-
hibitors may exacerbate them.27,28 The protective mecha-
nism of HO-1 is attributable to its byproducts, CO and
biliverdin, which are vasodilators that improve liver
microcirculation and reduce hepatocellular apoptosis and
necrosis.29
NO is synthesized from L-arginine by the NOS family of
enzymes. Two NOS isoforms were previously identified:
constitutive NOS and iNOS.30 Constitutive NOS comprises
endothelial NOS (eNOS) and neuronal NOS. NO plays a
crucial role in the homeostasis of hepatic circulation under
physiological conditions.31,32 Furthermore, a large amount
of NO is produced in response to various stress-related
conditions including hepatic ischemiaereperfusion.33
Under a stable condition, only the physiological amount
of NO produced by eNOS maintains hepatic vascular tone.34
Nevertheless, the large amount of NO produced by iNOS
induces vasodilatation.35 Therefore, the induction and
activation of iNOS constitute a crucial biological mechanism
for coping with stress-related conditions.32
The heat shock response is induced by various stimuli
including thermal, chemical, and physical stresses as well
as short-term ischemia.36 Organisms typically respond to
such detrimental insults by inducing a group of protective
proteins called HSPs. HSPs are classified into multimember
families on the basis of the molecular weights of protein
they encode (HSP90, HSP70, HSP60, and the small HSP
family). HSP70 is one of the most extensively studied
mammalian HSPs.36,37 HSPs, particularly HSP70, play a
major role in thermotolerance as well as in protecting
against oxygen radical toxicity and ischemia-reperfusion
injury.38
PCNA levels are directly correlated with cell prolifera-
tion and DNA synthesis rates and with the cell proliferative
state.14,39 Prelich et al40 studied post-hepatectomy regen-
eration in mice and reported that regeneration with PCNA-
positive cell augmentation increased after 24 hours. Tanoue
et al41 demonstrated that a 50% reduced liver promoted
hepatic remnant regeneration, which was accentuated by
N-acetylcysteine, according to the total hepatocyte num-
ber and PCNA levels.
In previous studies, the effects of ischemic pre-
conditioning have been generally evaluated immediately or
a few hours after the maneuver is performed. To the best ofour knowledge, our study is the first to evaluate the long-
term effects of ischemic preconditioning (on the 2nd day, 24
hours later) and demonstrate that both PCNA and HO-1
expressions significantly increased after the longer hepat-
ic ischemia (45 minutes), which decreased with ischemic
preconditioning. Because longer ischemic insults probably
induce more reactive production of PCNA and HO-1, PCNA
and HO-1 expressions may have significantly increased after
45-minute ischemia compared with that after 30-minute
ischemia. Nevertheless, why ischemic preconditioning
significantly reduced PCNA and HO-1 expressions in the 45-
minute ischemia groups remains unknown. Whether the
long-term effects of ischemic preconditioning stabilize the
liverdresulting in reduced PCNA and HO-1 expressions
after 45-minute ischemiadwarrants further elucidation.
Hypoxia-inducible factor (HIF)-1 and HIF-2 are hetreo-
dimeric basic helixeloopehelix transcription factors from
the PereARNTeSim family.42 Their basic helixeloopehelix
domains mediate dimerization and bind to contact the DNA
of target genes and activate transcription.43
HIFs are universal cellular oxygen-sensitive transcription
factors that activate several hypoxia-responsive genes,
some of which are responsible for protective cellular
functions.44 During organ donation, allografts are exposed
to hypoxia and ischemia for significant periods. Exploiting
this pathway during donor management and organ preser-
vation may prevent or reduce allograft injury and improve
organ transplantation outcomes.44 The role of HIFs war-
rants exploration in a future study.Acknowledgments
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